Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - Form 6-K
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - AND - MANAGEMENT INFORMATION CIRCULAR ... | April 6, 2023
Stay updated with breaking news from Sanofi Pasteur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - AND - MANAGEMENT INFORMATION CIRCULAR ... | April 6, 2023
Our lead drug candidate, obefazimod, has generated promising results in Phase IIa and Phase IIb clinical trials for the treatment of ulcerative colitis, a chronic inflammatory bowel disease, and in a Phase IIa clinical trial in rheumatoid arthritis.
AstraZeneca (OTCMKTS:AZNCF – Get Rating) and Sanofi (NYSE:SNY – Get Rating) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, earnings, profitability, valuation, risk, institutional ownership and dividends. Valuation & Earnings This table compares AstraZeneca and Sanofi’s gross revenue, […]
AstraZeneca (OTCMKTS:AZNCF – Get Rating) and Sanofi (NYSE:SNY – Get Rating) are both health technology companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends. Dividends AstraZeneca pays an annual dividend of $2.80 per share and […]
AstraZeneca (OTCMKTS:AZNCF – Get Rating) and Sanofi (NYSE:SNY – Get Rating) are both health technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, risk, profitability, analyst recommendations and dividends. Valuation and Earnings This table compares AstraZeneca and Sanofi’s revenue, earnings […]